SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-20-125819
Filing Date
2020-11-16
Accepted
2020-11-16 16:16:14
Documents
67
Period of Report
2020-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q tm2029570-1_10q.htm 10-Q 632928
2 EXHIBIT 10.2 tm2029570d1_ex10-2.htm EX-10.2 56517
3 EXHIBIT 31.1 tm2029570d1_ex31-1.htm EX-31.1 7831
4 EXHIBIT 31.2 tm2029570d1_ex31-2.htm EX-31.2 7765
5 EXHIBIT 32.1 tm2029570d1_ex32-1.htm EX-32.1 4410
6 EXHIBIT 32.2 tm2029570d1_ex32-2.htm EX-32.2 4289
  Complete submission text file 0001104659-20-125819.txt   5607414

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT ontx-20200930.xml EX-101.INS 1480679
8 XBRL TAXONOMY EXTENSION SCHEMA ontx-20200930.xsd EX-101.SCH 47465
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ontx-20200930_cal.xml EX-101.CAL 36628
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ontx-20200930_def.xml EX-101.DEF 186610
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE ontx-20200930_lab.xml EX-101.LAB 422540
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ontx-20200930_pre.xml EX-101.PRE 321182
Mailing Address 375 PHEASANT RUN NEWTOWN PA 18940
Business Address 375 PHEASANT RUN NEWTOWN PA 18940 267-759-3681
Onconova Therapeutics, Inc. (Filer) CIK: 0001130598 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36020 | Film No.: 201317124
SIC: 2834 Pharmaceutical Preparations